Spinal Fusion Devices Market

The Spinal Fusion Devices Market is valued at USD 9.33 Bn in 2026 and is projected to reach USD 12.4 Bn,  growing at a CAGR of 4% by 2033.

Robotics in Spinal Fusion to Offer New Growth Pathways for Spinal Fusion Devices Market

Increasing prevalence of spinal cord injuries on the back of factors such as poor weight management, no physical activity, and poor lifestyle practices has become a major topic of concern. According to the 2020 report of National Health Portal of India, around 250,000 to 500,000 individuals suffer from spinal cord injuries on the global front. This has resulted in an increase in spinal procedures to overcome spinal imbalance and restore stability in the structure. This factor remains instrumental in driving the demand for spinal fusion devices, consequently aiding the growth of spinal fusion devices market.

With technology and healthcare going together, the development of advanced medical devices has transformed the industry since past few years. In view of reducing human errors and increasing patient outcome and success, medical device companies are leveraging technology to develop surgical robots. The adoption of surgical robotics in the spine industry has gradually been enabling several hospitals, and other healthcare facilities to treat the various spinal disorders. Companies are taking efforts to develop surgical robots that could be applied in the spinal fusion procedures along with implants and other navigation tools. With this technology, the time for performing complex procedures would reduce significantly, thus contributing towards patient success. In this backdrop, deepening penetration of robotics in the spinal space is expected to provide ample opportunities for the spinal fusion devices market.

Lumbar Fusion Devices to Largely Contribute Toward Revenue Growth of Spinal Fusion Devices Market

The demand for lumbar fusion devices is expected to increase significantly on the back of rising spinal fusions performed worldwide. Lumbar fusion being a complex procedure, it involves high risks with longer recovery period post procedure. This has fuelled the need for advanced lumbar fusion devices that can support the spinal structure and the vertebrae. In addition, increasing number of lumbar fusions has accelerated the adoption of lumbar fusion devices. For instance, according to AHRQ (Agency for Healthcare Research and Quality), lumbar fusions are the most commonly performed surgeries in the US. Approximately 210,000 lumbar procedures are performed in the country and the count is likely to increase in the forthcoming years.

Moreover, companies are gaining FDA clearances to commercialize their lumbar fusion devices. For example, in 2020, 510 (K) clearance was received by 4WEB Medical from the FDA for the company’s standalone Anterior Lumbar Interbody Fusion Device. That said, increasing lumbar procedures and new product launches in this space is expected to drive the adoption of lumbar fusion devices, in turn complementing the growth of the spinal fusion devices market.

North America’s Spinal Fusion Devices Market Continues to Witness a Demand Surge

The demand for spinal fusion devices across developed countries in North America is expected to witness a spike in the coming years. This is mainly due to increasing spinal cord injuries and growing number of individuals suffering from spine related issues such as lower back pain. For instance, according to National Spinal Cord Injury Statistical Centre, the incidence of SCI (Spinal Cord Injury) in United States is approximately 54 cases in one million individuals, which roughly amounts to 17,800 new spinal cord injury cases each year in the country. This has resulted in an increased mental and economic burden on individuals in the region, which is expected to drive the need for spinal fusion devices. By using these devices, the entire spinal structure can be stabilized during an injury or trauma. This has propelled their adoption in developed nations such as the United States, in turn complementing the value growth of the spinal fusion devices market in North America.

In addition, the region shelters several major players involved in providing spinal fusion devices. This is mainly owing to macro factors such as strong economic growth, stable increase in GDP per capita, inclination towards using advanced devices to reduce trauma, robust healthcare infrastructure and increasing geriatric patient pool. In wake of this scenario, companies manufacturing spinal fusion devices are adopting strategic initiatives to maintain growth. For instance, in 2021, a proprietary and unique surface technology – BIOBraille – was acquired by Spectrum Spine for spinal trauma and the company has started its operations with the technology. Also, in 2020, the US Food and Drug Administration (FDA) gave approval for Spineology Interbody Fusion System referred to as OptiMesh Expandable Interbody Fusion System developed by Spineology Inc. Such developments from a competitive standpoint coupled with increasing need for these devices has significantly boosted the growth of the spinal fusion devices market in North America.

New product launches, collaborations, acquisitions, and partnerships are being witnessed in the spinal fusion devices market. For instance, in July 2021 Fusion Robotics LLC and Integrity Implants Inc. concluded their merger and rebranded to fuel the adoption of their minimally invasive services for spinal care. In 2020, FIBRINET was acquired by Royal Biologics. With this acquisition, Royal’s portfolio will expand to support spinal fusion by offering novel biologic solution to orthopaedic surgeons. In June 2022, DEXA SOLO-L, Aurora Spine’s ALIF (Anterior Lumbar Interbody Fusion Device) was granted FDA clearance. Same year, Camber Spine announced the initiation of the next launch phase of SPIRA-P, its posterior lumbar spacer while alongside commercializing its SPIRA-T, its oblique posterior lumbar spacing device. Such developments remain a crucial factor in bolstering the spinal fusion devices market growth.

A few of the major players in the spinal fusion devices market include 

• Medtronic plc
• DePuy Synthes (Johnson & Johnson)
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• NuVasive, Inc.
• Globus Medical, Inc.
• K2M (acquired by Stryker)
• Orthofix International N.V.
• LimaCorporate
• Amedica Corporation
• Braun Melsungen AG
• Smith & Nephew plc
• RTI Surgical (acquired by Aetna)
• CareDx, Inc. (spinal implant analytics/adjunct technologies)
• Alphatec Spine, Inc.

By Product

• Thoracolumbar Devices
  • Anterior Lumbar Plates
  • Pedicle Screw and Rods
  • Others
• Cervical Fixation Devices
  • Anterior Cervical Plates
  • Hook Fixation Systems
  • Others
• Interbody Fusion Devices

By Disease

• Other Nondestructive Technologies
• Degenerative Disc
• Complex Deformity
• Trauma & Fractures
• Others

By Surgery

• Open Spine Surgery
• Minimally Invasive Spine Surgery

By End Use

• Hospitals
• Outpatient Facilities

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)